Cargando…
The effect of Huashibaidu formula on the blood oxygen saturation status of severe COVID-19: A retrospective cohort study
BACKGROUND: Huashibaidu Formula (HSBD) for the COVID-19 treatment has been supported by the China's Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia. However, it is not clear whether HSBD can improve blood oxygen saturation and when it should be used with conventional therapies....
Autores principales: | Xiong, Yibai, Tian, Yaxin, Ma, Yan, Liu, Bin, Ruan, Lianguo, Lu, Cheng, Huang, Luqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier GmbH.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641428/ https://www.ncbi.nlm.nih.gov/pubmed/34929564 http://dx.doi.org/10.1016/j.phymed.2021.153868 |
Ejemplares similares
-
Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical Trial
por: Zhao, Chen, et al.
Publicado: (2021) -
A Longitudinal Cohort Study Using a Modified Child-Pugh Score to Escalate Respiratory Support in COVID-19 Patients — Hubei Province, China, 2020
por: Xiong, Yibai, et al.
Publicado: (2021) -
Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19
por: Zhang, Fangbo, et al.
Publicado: (2023) -
Comparing different machine learning techniques for predicting COVID-19 severity
por: Xiong, Yibai, et al.
Publicado: (2022) -
Effectiveness of Chinese medicine formula Huashibaidu granule on mild COVID-19 patients: A prospective, non-randomized, controlled trial
por: Chen, Bowu, et al.
Publicado: (2023)